跳至主要内容
临床试验/NL-OMON35935
NL-OMON35935招募中不适用

Efficacy of a three novel compounds in a humanized mouse model of psoriasis - Pre-clinical efficacy of 3 compounds in psoriasis

Pfizer0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Pfizer
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Psoriasis patients: Adults (m/f) with a mild form of psoriasis vulgaris (PASI score of maximal 6). Patients areallowed to use local corticosteroids or ointments to prevent dry skin (see Appendix 2).

排除标准

  • Psoriasis patients: These patients have not received light therapy or another form of systemic treatment (methotrexate, cyclosporin A, anti-TNF treatments). Gender or age of the adults are not exclusion criteria (see Appendix 2).

研究者

发起方
Pfizer

相似试验